Cathy Friedman, Director at Lyell Immunopharma, Inc. (LYEL), bought 3,783,490 shares at $17.00 ($300K) on 2021-06-21, disclosed to the SEC on 2021-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,765,842 | $0 | 0.0% |
| 2 | $17.00 | 17,648 | $300K | 100.0% |
| Total | $0.08 avg | 3,783,490 | $300K | 100% |
| Filing → |
| XNPT | BUY | 2008-03-18 | $98K | — | Filing → |